Dermal Eccrine Cylindroma

Search Trials
Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate
Status:
Completed
Last Changed:
Jul 6, 2012
First Changed:
Dec 1, 2010
Disease(s):
Cancer
Intervention(s):
Imatinib mesylate, Cyclophosphamide (Dosing level 1 )Imatinib mesylate, Cyclophosphamide (Dosing level 2)Imatinib mesylate, Cyclophosphamide (Dosing level 3)Blood sampling

Connect. Empower. Inspire.